Latest Breaking News On - Luke schmerold - Page 1 : comparemela.com

Helsinn publishes results from a secondary analysis of a Phase 3 trial in patients with CINV in The Oncologist Lugano, Switzerland, January 4, 2023 - Helsinn Group ("Helsinn")

United statesAlex molassiotisPaola bonviciniEros papademetriouKelseya kluteLee schwartzbergLuke schmeroldKostenloser wertpapierhandelDwightd klothGary binderThomasw leblancEricj roelandRudolph navariGroup head of communicationHelsinn groupHelsinn birex pharmaceuticals ltd